INS and diabetes mellitus: In the diabetes reversal arm of the current study, we observed that the combination of GABA and sitagliptin reduced blood glucose levels and lowered exogenous insulin demand, however the GABA and sitagliptin combination was significantly less effective than the triple combination therapy and did not significantly increase C-peptide and insulin levels in the mice.